Professor Carmel Hawley
Professor

Carmel Hawley

Email: 
Phone: 
+61 7 3176 2625

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

715 works between 1965 and 2025
All (715) Journal Article (484) Book Chapter (6) Conference Publication (223) Other Outputs (2)

501 - 520 of 715 works

2009

Journal Article

Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients

Badve, Sunil V., Smith, Alicia, Hawley, Carmel M. and Johnson, David W. (2009). Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients. Clinical Kidney Journal, 2 (6), 508-509. doi: 10.1093/ndtplus/sfp095

Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients

2009

Journal Article

Reply

Barraclough, Katherine, Hawley, Carmel M., McDonald, Stephen .P, Brown, Fiona G., Rosman, Johan B., Wiggins, Kathryn J., Bannister, Kym .M and Johnson, David W. (2009). Reply. Nephrology Dialysis Transplantation, 24 (12), 3897-3898. doi: 10.1093/ndt/gfp466

Reply

2009

Journal Article

In Reply to ‘Intramuscular or Intradermal Hepatitis B Vaccine Administration in Hemodialysis Patients?’

Barraclough, Katherine A., Hawley, Carmel M. and Playford, E. Geoffrey (2009). In Reply to ‘Intramuscular or Intradermal Hepatitis B Vaccine Administration in Hemodialysis Patients?’. American Journal of Kidney Diseases, 54 (5), 982-982. doi: 10.1053/j.ajkd.2009.08.009

In Reply to ‘Intramuscular or Intradermal Hepatitis B Vaccine Administration in Hemodialysis Patients?’

2009

Journal Article

Association of dialysis modality and cardiovascular mortality in incident dialysis patients

Johnson, David W., Dent, Hannah, Hawley, Carmel M., McDonald, Stephen P., Rosman, Johan B., Brown, Fiona G., Bannister, Kym and Wiggins, Kathryn J. (2009). Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clinical Journal of the American Society of Nephrology, 4 (10), 1620-1628. doi: 10.2215/CJN.01750309

Association of dialysis modality and cardiovascular mortality in incident dialysis patients

2009

Journal Article

Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study

Kaisar, Mohd, Armstrong, Kirsten, Hawley, Carmel, Campbell, Scott, Mudge, David, Johnson, David W., Prins, John B. and Isbel, Nicole M. (2009). Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study. BMC Nephrology, 10 (29) 29, xxx-xxx. doi: 10.1186/1471-2369-10-29

Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study

2009

Journal Article

Recovery of renal function in end-stage renal failure – Comparison between peritoneal and haemodialysis

Macdonald, James A., McDonald, Stephen P., Hawley, Carmel M., Rosman, Johan, Brown, Fiona, Wiggins, Kathryn J., Bannister, Kym and Johnson, David W. (2009). Recovery of renal function in end-stage renal failure – Comparison between peritoneal and haemodialysis. Nephrology Dialysis Transplantation, 24 (9), 2825-2831. doi: 10.1093/ndt/gfp216

Recovery of renal function in end-stage renal failure – Comparison between peritoneal and haemodialysis

2009

Conference Publication

Prevalence of Vitamin D Deficiency in a Subtropical Incentre Haemodialysis Population

Miles, R., Herzig, K., Bofinger, A. and Hawley, C. (2009). Prevalence of Vitamin D Deficiency in a Subtropical Incentre Haemodialysis Population. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, TAS Australia, 7–9 September 2009. Richmond, VIC Australia: John Wiley and Sons.

Prevalence of Vitamin D Deficiency in a Subtropical Incentre Haemodialysis Population

2009

Journal Article

Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of catheter associated infecTion in haemodialysis patients

Broom, Jennifer, O'Shea, Stacey, Govindarajula, Sridevi, Playford, Geoffrey, Hawley, Carmel M., Isbel, Nicole M., Campbell, Scott, Mudge, David, Carpenter, Sally, Johnson, Barbara, Underwood, Neil and Johnson, David W. (2009). Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of catheter associated infecTion in haemodialysis patients. BMC Nephrology, 10 (23) 23, xxx-xxx. doi: 10.1186/1471-2369-10-23

Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of catheter associated infecTion in haemodialysis patients

2009

Journal Article

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)

Barraclough, Katherine A., Noble, Euan, Leary, Diane, Brown, Fiona, Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Mudge, David, van Eps, Carolyn L., Sturtevant, Joanna M. and Johnson, David W. (2009). Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial). BMC Nephrology, 10 (1) 20, 20-1-20-7. doi: 10.1186/1471-2369-10-20

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)

2009

Journal Article

Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: A prospective open-label randomized controlled trial in nonresponders to primary vaccination

Barraclough, Katherine A., Wiggins, Kathryn J, Hawley, Carmel M., van Eps, Carolyn L., Mudge, David W., Johnson, David W., Whitby, Michael, Carpenter, Sally and Playford, E. Geoffrey (2009). Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: A prospective open-label randomized controlled trial in nonresponders to primary vaccination. American Journal of Kidney Diseases, 54 (1), 95-103. doi: 10.1053/j.ajkd.2009.03.010

Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: A prospective open-label randomized controlled trial in nonresponders to primary vaccination

2009

Journal Article

Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases

O'Shea, Stacey, Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Rosman, Johan B., Wiggins, Kathryn J., Bannister, Kym M. and Johnson, David W. (2009). Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases. BMC Nephrology, 10 (1) 19, 19.1-19.9. doi: 10.1186/1471-2369-10-19

Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases

2009

Journal Article

International quotidian dialysis registry: Annual report 2009

Nesrallah, Gihad E., Suri, Rita S., Moist, Louise M., Cuerden, Meaghan, Groeneweg, Karen E., Hakim, Raymond, Ofsthun, Norma J., McDonald, Stephen P., Hawley, Carmel, Caskey, Fergus J., Couchoud, Cecile, Awaraji, Christian and Lindsay, Robert M. (2009). International quotidian dialysis registry: Annual report 2009. Hemodialysis International, 13 (3), 240-249. doi: 10.1111/j.1542-4758.2009.00391.x

International quotidian dialysis registry: Annual report 2009

2009

Journal Article

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients

Mudge, David, Tan, Ken-Soon, Miles, Rhianna, Johnson, David W., Campbell, Scott, Hawley, Carmel M., Isbel, Nicole M., Van Eps, Carolyn and Nicol, David L. (2009). Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients. BMC Nephrology, 10 (1) 14, 14.1-14.3. doi: 10.1186/1471-2369-10-14

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients

2009

Journal Article

Life-threatening adenovirus infection in a kidney transplant recipient

Barraclough, Katherine, Oliver, Kimberley, Playford, Elliot Geoffrey, Preston, John, Campbell, Scott, Johnson, David W., Hawley, Carmel, Mudge, David, van Eps, Carolyn and Isbel, Nicole (2009). Life-threatening adenovirus infection in a kidney transplant recipient. NDT Plus, 2 (3), 250-253. doi: 10.1093/ndtplus/sfp003

Life-threatening adenovirus infection in a kidney transplant recipient

2009

Journal Article

The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients

Johnson, D. W, Clark, C, Isbel, N, Hawley, C, Beller, E, Cass, A, de Zoysa, J, McTaggart, S, Playford, G, Rosser, B, Thompson, C and Snelling, P (2009). The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Peritoneal Dialysis International, 29 (3), 303-309. doi: 10.1177/089686080902900315

The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients

2009

Journal Article

Predicting Risk of Nonmelanoma Skin Cancer and Premalignant Skin Lesions in Renal Transplant Recipients

Urwin, H. R., Jones, P. W., Harden, P. N., Ramsay, H. M., Hawley, C. M., Nicol, D. L. and Fryer, A. A. (2009). Predicting Risk of Nonmelanoma Skin Cancer and Premalignant Skin Lesions in Renal Transplant Recipients. Transplantation, 87 (11), 1667-1671. doi: 10.1097/TP.0b013e3181a5ce2e

Predicting Risk of Nonmelanoma Skin Cancer and Premalignant Skin Lesions in Renal Transplant Recipients

2009

Conference Publication

Renal cell carcinoma of the renal allograft - A case series and review of the literature

Fahim, M., Mark, S., Hawley, C. and Robson, R. (2009). Renal cell carcinoma of the renal allograft - A case series and review of the literature. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Tasmania, Australia, 7-9 September 2009. Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2009.01176.x

Renal cell carcinoma of the renal allograft - A case series and review of the literature

2009

Conference Publication

Vascular structure and function in alternate nightly nocturnal haemodialysis

Van Eps, C. L., Jeffries, L., Haluska, B., Hawley, C. M., Jeffries, J., Johnson, D. W., Campbell, S. B., Isbel, N. M., Mudge, D. W. and Marwick, T. H. (2009). Vascular structure and function in alternate nightly nocturnal haemodialysis. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology , Hobart, Tasmania, Australia, 7–9 September 2009. Hoboken, NJ United States: Wiley-Blackwell.

Vascular structure and function in alternate nightly nocturnal haemodialysis

2009

Conference Publication

The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events

Kaisar, M, Armstrong, K, Hawley, C, Pidcock, R, Johnson, D, Prins, JB, Marwick, T and Isbel, N (2009). The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Australia, 7 - 9 September, 2009. Carlton, Australia: Wiley Interscience.

The impact of aggressive risk factor modification in renal transplant recipients with impaired glucose tolerance or diabetes on the development of de novo cardiac events

2009

Conference Publication

STREPTOCOCCAL PERITONITIS IN AUSTRALIAN PERITONEAL DIALYSIS PATIENTS: PREDICTORS, TREATMENT AND OUTCOMES

O'Shea, S, Hawley, CM, McDdonald, SP, Brown, FG, Rosman, JB, Wiggins, KJ, Bannister, KM and Johnson, DW (2009). STREPTOCOCCAL PERITONITIS IN AUSTRALIAN PERITONEAL DIALYSIS PATIENTS: PREDICTORS, TREATMENT AND OUTCOMES. 45th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Hobart, Australia, 7-9 September 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

STREPTOCOCCAL PERITONITIS IN AUSTRALIAN PERITONEAL DIALYSIS PATIENTS: PREDICTORS, TREATMENT AND OUTCOMES

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant
  • 2021 - 2027
    An adaptive, randomised controlled trial to treat polyomavirus infections (BKPyV) in kidney and kidney pancreas transplant recipients (BEAT-BK) trial (MRFF RCRDUN led by USyd)
    University of Sydney
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2020 - 2025
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC CTCS administered by USYD)
    University of Sydney
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au